ClinicalTrials.govpublic full text
A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma
multiple myeloma, neoplasms, neoplasm, plasma cell, gammopathy, monoclonal, paraproteinemias, blood protein disorders, haematologic disease, corneal disease, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 909622
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.